Cyclin D1 and p16(INK4A) expression predict reduced survival in carcinoma of the anterior tongue

Clinical Cancer Research

Volumn 5, Issue 10, 1999, Pages 2810-2819

  Bova, Ronaldo J ^a   Quinn, David I ^a   Nankervis, Jane S ^c   Cole, Ian E ^a   Sheridan, Brian F ^a   Jensen, Michael J ^a   Morgan, Gary J ^b   Hughes, Christopher J ^a   Sutherland, Robert L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P16; KI 67 ANTIGEN; PROTEIN P16INK4A; PROTEIN P53;

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; CHEMISTRY; FEMALE; LYMPH NODE METASTASIS; MALE; MORTALITY; PATHOLOGY; TONGUE TUMOR;

CARCINOMA, SQUAMOUS CELL; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; TONGUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032589742     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer, 80: 827-841, 1999.
2. Spitz, M. R., Fueger, J. J., Goepfert, H., Hong, W. K., and Newell, G. R. Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis. Cancer (Phila.), 61: 203-208, 1988.
3. Schottenfeld, D. Alcohol as a co-factor in the etiology of cancer. Cancer (Phila.), 43: 1962-1966, 1979.
4. Merletti, F., Boffetta, P., Ciccone, G., Mashberg, A., and Terracini, B. Role of tobacco and alcoholic beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, Italy. Cancer Res., 49: 4919-4924, 1989.
5. Spiro, R. H., and Strong, E. W. Surgical treatment of cancer of the tongue. Surg. Clin. N. Am., 54: 759-765, 1974.
6. Pignataro, L., Pruneri, G., Carboni, N., Capaccio, P., Cesana, B. M., Neri, A., and Buffa, R. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J. Clin. Oncol., 16: 3069-3077, 1998.
7. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
8. Hunter, T., and Pines, J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
9. Califano, J., Vanderriet, P., Westra, W., Nawroz, H., Clayman, G., Piantadosi, S., Corio, R., Lee, D., Greenberg, B., Koch, W., and Sidransky, D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res., 56: 2488-2492, 1996.
10. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
11. Hall, M., and Peters, G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res., 68: 65-108, 1996.
12. Masuda, M., Hirikawa, N., Nackashima, T., Kuratomi, Y., and Komiyama, S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer (Phila.), 78: 390-395, 1996.
13. Akervall, J. A., Michalaides, R. J., Mineta, H., Balm, A., Borg, A., and Dictor, M. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer (Phila.), 79: 380-389, 1997.
14. Michalaides, R. J., van Heelen, N. M. J., Kristel, P. M. P., Hart, A. A. M., Loftus, B. M., and Hilgers, F. J. M. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 123: 497-502, 1997.
15. Kyomoto, R., Kumazawa, H., Toda, Y., Sakaida, N., Okamura, A., Iwanga, M., Shintaku, M., Yamashita, T., Hiai, H., and Fukumoto, M. Cyclin D1 gene amplification is a more potent prognostic factor than its protein overexpression in human head and neck squamous cell carcinoma. Int. J. Cancer, 74: 576-581, 1997.
16. Williams, M. E., Gaffey, M. J., Lawrence, M. W., Wilczynski, S. P., Schuuring, E., and Levine, P. A. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch. Otolarynyngol. Head Neck Surg., 119: 1238-1243, 1993.
17. Muller, D., Millon, M., Velten, M., Bronner, G., Jung, G., and Engelmen, H. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome. Eur. J. Cancer, 33: 2203-2210, 1997.
18. INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta, 1378: F115-F177, 1998.
19. Liggett, W. H., and Sidransky, D. Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol., 16: 1197-1206, 1998.
20. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., and Koch, W. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res, 351: 3630-3633, 1996.
21. INK4a in oral premalignant lesions. Oncogene, 14: 1799-1803, 1997.
22. Boyle, J. O., Hakim, J., Koch, W., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
23. Shim, D. M., Kim, J., and Ro, J. Y. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res., 54: 321-326, 1994.
24. Brennan, J. A., Mao, L., Hruban, R. H., Boyle, J. O., Eby, Y. J., Koch, W. M., Goodman, S. N., and Sidransky, D. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332: 429-435, 1995.
25. Ahomadegbe, J. C., Barrois, M., and Fogel, S. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases. Absence of correlation with clinical outcome: frequent protein overexpression in normal epithelium and in early non invasive lesions. Oncogene, 10: 1217-1227, 1995.
26. Koch, W. M., Brennan, J. A., Zahvrak, M., Goodman, S. N., Westra, W. H., Schwab, D., Yoo, G. H., Jenlee, D., and Sidransky, D. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J. Natl. Cancer Inst., 88: 1580-1586, 1996.
27. Alle, K. M., Henshall, S. M., Field, A. S., and Sutherland, R. L. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin. Cancer Res., 4: 847-854, 1998.
28. Buckley, M. F., Sweeney, K. J., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., deFazio, A., Watts, C. K., Musgrove, E. A., and Sutherland, R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8: 2127-2133, 1993.
29. WAF1/CIP1 in human breast cancer. Int. J. Cancer, 63: 584-591, 1995.
30. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., and Paulson, D. F. Isolation of a human prostatic carcinoma cell line (DU 145). Int. J. Cancer, 21: 274-281, 1978.
31. INK4a in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res, 55: 6006-6011, 1995.
32. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
33. Cox, D. R. Regression models and life tables (with discussion). J. R. Stat. Soc., 34: 187-189, 1972.
34. Kotelnikov, V. M., Coon, J. S., Mundle, S., Kelanic, S., Lafollette, S., Taylor, S., Hutchinson, J., Panje, W., Caldarelli, D. D., and Preisler, H. D. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin. Cancer Res., 3: 95-101, 1997.
35. 1 regulation in human head and neck cancer. Cancer Res., 55: 949-956, 1995.
36. Mineta, H., Borg, A., Dictor, M., Walhberg, P., and Wennerberg, J. Correlation between p53 and cyclin D1 amplification in head and neck carcinoma. Oral Oncol., 33: 42-46, 1997.
37. Nogueira, C. P., Dolan, R. W., Gooey, J., Byahatti, S., Vaughan, C. W., Fuleihan, N. S., Grillone, G., Baker, E., and Domanowski, G. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope, 108: 345-350, 1998.
38. Nylander, K., Schildt, E. B., Eriksson, M., and Roos, G. PCNA, Ki-67, p53, bcl-2 and prognosis in intraoral squamous cell carcinoma of the head and neck. Ann. Cell Pathol., 14: 101-110, 1997.
39. James, P., Fernandez, P. L., Campo, E., Nadel, A., Bosch, F., and Aiza, G. PRAD 1/CYCLIN D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res., 54: 4813-4817, 1994.
40. Wang, X., Pavelic, Z. P., Li, Y. Q., Gleich, L., Radack, K., Gluckman, J. L., and Sambrook, P. J. Amplification and overexpression of the cyclin D1 gene in head and neck squamous cell carcinoma. J. Clin. Pathol. Mol. Pathol., 48: M256-M259, 1995.
41. Fortin, A., Guerry, M., Guerry, R., Talbot, M., Parise, O., and Schwaab, G. Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence. Clin. Cancer Res., 3: 1609-1614, 1997.
42. Skapek, S. X., Rhee, J., Spicer, D. B., and Lassar, A. B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science (Washington DC), 267: 1022-1024, 1995.
43. Chandrasekaran, C., Coopersmith, C. M., and Gordon, J. I. Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators. J. Biol. Chem., 271: 28414-28421, 1996.
44. Grandis, J. R., Melhem, M. F., Gooding, W. E., Day, R., Holst, V. A., Wagener, M. M., Drenning, S. D., and Tweardy, D. J. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J. Natl. Cancer Inst., 90: 824-832, 1998.
45. 1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA, 91: 8022-8026, 1994.
46. Portugal, L. G., Goldenberg, J. D., Wenig, B. L., Ferrer, K. T., Nodzenski, E., Sabnani, J. B., Javier, C., Eichselbaum, R. R., and Vokes, E. E. Human papilloma virus expression and p53 gene mutations in squamous cell carcinoma. Arch. Otalarynogol. Head Neck Surg., 123: 1230-1234, 1997.
47. Veneroni, S., Silverstrini, R., Costa, A., Salvatori, P., Faranda, A., and Molinari, R. Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx. Oral Oncol., 33: 408-413, 1997.
48. van Heerden, W. F., van Rensburg, E. J., Hemmer, J., Raubenheimer, E. J., and Engelbrecht, S. Correlation between p53 gene mutation, p53 protein labeling and PCNA expression in oral squamous cell carcinoma. Anticancer Res., 18: 237-240, 1998.
49. Wilentz, R. E., Geradts, J., Maynard, R., Offerhaus, G., Kang, M., Goggins, M., Yeo, C. J., Kern, S. E., and Hruban, R. H. Inactivation of the p16 (ink4a) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res., 58: 4740-4744, 1998.
50. Li, H., Nichols, M. A., Shay, J. W., and Xiong, Y. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res., 54: 6078-6082, 1994.
51. INK4/MTS1 tumour suppressor gene product. EMBO J., 14: 503-511, 1995.
52. Lydiatt, W. M., Davidson, B. J., Schantz, S. P., Caruana, S., and Chaganti, R. 9p21 deletion correlates with recurrence in head and neck cancer. Head Neck, 20: 113-118, 1998.